[Expression of Concern] MicroRNA‑195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways. [PDF]
Sun P +9 more
europepmc +1 more source
Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report. [PDF]
Akazawa Y +12 more
europepmc +1 more source
Combinational Inhibition of the eIF4F Complex, AKT1, and EZH2 Enhances Anticancer Effects in BRAF<sup>V600E</sup> Mutant A375 Melanoma Cells. [PDF]
Miao Y, Hao F, Ki SH.
europepmc +1 more source
NX-1607: lifting the Cbl-b brake to promote T cell activation through MAPK/ERK pathways. [PDF]
To A, Sugimura R.
europepmc +1 more source
Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). [PDF]
Aloliqi AA +4 more
europepmc +1 more source
BRAF inhibitor-induced necrotizing granulomatous lymphadenopathy: a case report of drug-induced sarcoid-like reaction. [PDF]
Firouzbakht S +4 more
europepmc +1 more source
Oncogenic B-Raf proto-oncogene, serine/threonine kinase-mediated hedgehog signalling in the pathogenesis and targeted therapy of melanoma. [PDF]
Rather RA.
europepmc +1 more source
Encorafenib plus binimetinib versus dabrafenib plus trametinib for the first-line treatment of patients with BRAF<sup>V600E</sup>-mutant metastatic non-small cell lung cancer: a matching-adjusted indirect treatment comparison. [PDF]
Planchard D +6 more
europepmc +1 more source
BRAF V600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in Mice. [PDF]
Tomassoni-Ardori F +9 more
europepmc +1 more source
Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]
Li N, Hu J, Bao G, Cai Z.
europepmc +1 more source

